204 related articles for article (PubMed ID: 10341195)
1. Hepatitis C virus RNA viremia in Central Africa.
Cancré N; Grésenguet G; Mbopi-Kéou FX; Kozemaka A; Si Mohamed A; Matta M; Fournel JJ; Bélec L
Emerg Infect Dis; 1999; 5(3):484-5. PubMed ID: 10341195
[No Abstract] [Full Text] [Related]
2. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
Alvarez M; Planelles D; Vila E; Montoro J; Franco E
Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
[No Abstract] [Full Text] [Related]
3. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
[No Abstract] [Full Text] [Related]
4. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
León P; Echevarría JM
Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
[No Abstract] [Full Text] [Related]
5. HCV positivity rate in the seronegative blood donors in China.
Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
[No Abstract] [Full Text] [Related]
6. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
[TBL] [Abstract][Full Text] [Related]
8. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
[TBL] [Abstract][Full Text] [Related]
9. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite antibody test result.
Seiskari T; Horsti J; Aittoniemi J
J Clin Virol; 2011 May; 51(1):90-1. PubMed ID: 21377410
[No Abstract] [Full Text] [Related]
10. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan, Mexico.
García-Montalvo BM; Macossay-Castillo M
Transfus Med; 2007 Dec; 17(6):488-90. PubMed ID: 18067653
[No Abstract] [Full Text] [Related]
11. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
[No Abstract] [Full Text] [Related]
12. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso.
Zeba MT; Sanou M; Bisseye C; Kiba A; Nagalo BM; Djigma FW; Compaoré TR; Nebié YK; Kienou K; Sagna T; Pietra V; Moret R; Simporé J
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s54-7. PubMed ID: 24599906
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia.
Al-Kubaisy WA; Al-Naib KT; Habib M
East Mediterr Health J; 2006; 12(1-2):204-10. PubMed ID: 17037239
[TBL] [Abstract][Full Text] [Related]
17. [Distribution of hepatitis C virus genotype in Dalian].
Xie Y; Xie C
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):872-3. PubMed ID: 19958651
[No Abstract] [Full Text] [Related]
18. Incidence of hepatitis C virus RNA in anti-HCV-negative plasma pools and blood products.
Saldanha J; Minor P
Vox Sang; 1996; 70(4):232-4. PubMed ID: 9123930
[No Abstract] [Full Text] [Related]
19. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
[No Abstract] [Full Text] [Related]
20. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
